CME vs. Robinhood Markets: Which Financial Stock Is a Better Buy in 2026?

Investors weighing the stability of a market infrastructure giant against the rapid expansion of a digital challenger face a difficult choice between CME Group (NASDAQ:CME) and Robinhood Markets (NASDAQ:HOOD) in 2026.

CME Group is an established leader in global derivatives, providing the critical infrastructure for professional hedging and risk management. Robinhood disrupted the retail brokerage landscape with its mobile-first approach and is now scaling into institutional services. Comparing them helps you choose between a high-margin incumbent and a high-growth challenger.

The case for CME

CME Group operates the primary marketplace for global derivatives, offering contracts across interest rates, energy, and agriculture. It manages several designated markets including the New York Mercantile Exchange and the Chicago Board of Trade. The company also relies on a concentrated group of users, as one clearing firm represented approximately 12% of transaction fees in 2025. Customer concentration like this adds a layer of risk to the business.

In its latest annual report for FY 2025, revenue reached nearly $6.5 billion, which was a 6.4% increase over the prior year. Net income for the period was close to $4.0 billion. This performance resulted in a net margin of approximately 62%, an increase from the 57.5% reported in 2024. This continued a multi-year trend of growth, as revenue has risen steadily from $5.6 billion in 2023.

As of its December 2025 balance sheet, the debt-to-equity ratio is approximately 0.1x, indicating that total debt is only a small fraction of shareholder equity. The current ratio is roughly 93.0x, indicating the company has significant short-term assets to cover its liabilities. Free cash flow for the year was nearly $4.2 billion, reflecting the strong cash generation of its exchange model.

The case for Robinhood Markets

Robinhood operates as a prominent brand among fintech stocks, offering services ranging from retail brokerage to digital banking. The company recently expanded its institutional reach through the acquisition of Rothera E&C and its prediction markets infrastructure. It manages approximately 27.0 million funded customer accounts across the U.S. and several international markets.

In FY 2025, revenue reached nearly $4.5 billion, representing a significant 51.6% increase compared to the previous year. Net income for the period was close to $1.9 billion. The company achieved a net margin of approximately 42.1%, which is a sharp turnaround from the net loss reported in 2023. This growth was driven by increased trading volumes and higher interest income.

According to its December 2025 balance sheet, the debt-to-equity ratio is roughly 1.3x, meaning total liabilities exceed shareholder equity. The current ratio is approximately 1.3x, indicating that current assets are sufficient to cover liabilities due within one year. Free cash flow for the fiscal year reached close to $1.6 billion. This cash generation supports the company's efforts to expand its international footprint.

Risk profile comparison

CME Group faces intense competition from global exchange operators such as Intercontinental Exchange (NYSE:ICE) and Cboe Global Markets (BATS:CBOE). The company also navigates a heavy regulatory environment where new transaction taxes or digital asset rules could impact volume. Systemic risks include potential cyberattacks and a reliance on third-party infrastructure providers like Google Cloud.

Robinhood is subject to scrutiny regarding its payment for order flow revenue and its best execution practices. It competes for retail and institutional dollars against traditional firms and exchanges like Nasdaq (NASDAQ:NDAQ). The company also faces operational risks from its reliance on Amazon (NASDAQ:AMZN) for web services and significant price volatility in Bitcoin (CRYPTO:BTC) and other digital assets.

Valuation comparison

Robinhood carries a significantly higher premium than CME, suggesting that investors are pricing in much more aggressive growth for the retail-focused platform.

Valuation metrics include sourcing from Financial Modeling Prep (FMP) and may differ from other data providers.

The P/S ratio measures the market cap divided by sales over the past twelve months. Meanwhile, the Forward P/E compares the stock price to future earnings estimates.

Which stock would I buy in 2026?

I'd go with CME Group. There is something deeply reassuring about a business that gets more valuable every time markets get volatile, which is exactly how CME works. In Q2 2026, the company posted record first-half revenue, its second-highest Q2 trading volumes ever, and returned over a billion dollars to shareholders through dividends and buybacks. Market data revenue hit a new record, up 20% year over year. This is a business that just keeps compounding.

Robinhood had an impressive Q2 2026 itself, with record revenue of $1.3 billion, up 32% year over year, and prediction markets growing more than tenfold. The platform is evolving fast, adding new asset classes and international reach through acquisitions. But the market reaction told a more cautious story. The headline earnings beat was partly driven by a one-time gain that will not repeat, and cryptocurrency revenue fell sharply in the quarter, leaving investors wondering how much of the momentum is sustainable.

CME is the kind of business that is easy to own through uncertainty. For investors thinking about the next decade, that steady compounding is hard to argue with.

Sara Appino has positions in Amazon. The Motley Fool has positions in and recommends Amazon and CME Group. The Motley Fool recommends Cboe Global Markets, Intercontinental Exchange, and Nasdaq. The Motley Fool has a disclosure policy.